Testing a new drug NTB003 in healthy volunteers
This early-phase trial tests the safety of a new drug called NTB003 in healthy people. It looks at how the drug moves through the body and affects it, which is a first step toward possibly treating certain conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 25 and 45 years old.
- Your body mass index (BMI) is between 19 and 26, and you weigh at least 50 kg (men) or 45 kg (women).
- You are generally healthy, with no major illnesses like heart, lung, or mental health conditions.
- You agree to use reliable birth control during the study and, if female, have a negative pregnancy test.
- You have not taken any medications, including over-the-counter drugs or supplements, in the last 2 weeks.
- You do not smoke more than 5 cigarettes a day and can avoid tobacco during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests how a new medicine (TBN) behaves in the body after several doses, including side effects and tolerability. It is meant for healthy adults to help researchers decide how it can be used safely in future studies.
This trial tests a new medicine called MT-201 to see if it is safe and how the body handles it. It is for healthy volunteers aged 19 to 55 who are willing to follow study rules.
This trial tests a new drug called NTB003 for people with moderate-to-severe thyroid eye disease (TED). It aims to see if the drug can improve symptoms like eye bulging and double vision, and it may be an option for those whose disease is active or has been ongoing for a while.
This trial tests a new drug, TL-001, in healthy volunteers to see if it is safe and how the body processes it. You may join if you are a healthy adult between 18 and 55.
This trial tests a new drug called CAY001 in healthy volunteers to see how safe it is and how the body processes it. It may help researchers understand if the drug is safe enough to test in people with medical conditions later.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
Hear when a new TED trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.